Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
about
Review and management of drug interactions with boceprevir and telaprevirHepatitis C virus-HIV-coinfected patients and liver transplantationChallenges in the treatment of HIV and HCV coinfection.Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients.Renal transplantation in patients with HIV.Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir.Liver transplantation in HCV/HIV positive patients.Metronidazole or Cotrimoxazole therapy is associated with a decrease in intestinal bioavailability of common antiretroviral drugs.Drug interactions in the management of HIV infection.Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in GermanySafety of lopinavir/ritonavir for the treatment of HIV-infection.Drug interactions in the management of HIV infection: an update.Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvirHIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.Solid organ transplants in HIV-infected patients.A clinician's guide to drug-drug interactions with direct-acting antiviral agents for the treatment of hepatitis C viral infection.Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.Lack of drug interaction between cyclosporine and telaprevir in a liver transplant recipient.Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.Human immunodeficiency virus in solid organ transplantation.Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.Pharmacokinetics of a three-way drug interaction between danoprevir, ritonavir and the organic anion transporting polypeptide (OATP) inhibitor ciclosporin.Hot topics in HIV and hepatitis coinfection: noninvasive diagnosis of liver disease, liver transplantation, and new drugs for treatment of hepatitis coinfection.
P2860
Q24628716-6FE6420E-F752-4B85-B18C-B59EF8A06591Q27011255-D8BDFE4D-DD8E-4E5F-B211-B5FF3ED64AE8Q30389282-D43A7D61-699E-4D1A-BAD3-1F75831F1DF0Q33599107-3C0A9C0C-AC16-48D3-9F15-85E7D9435280Q34079397-20FCF4DE-FAC3-4D82-9DD5-A2FAF42C92C6Q34633457-107A1AD4-8C65-4E26-910D-24697A1282AAQ34640985-A3E6A9EB-D4EA-45C2-BD2B-890410CC918CQ35108410-53840378-76F7-4B4F-8DFB-FAD02BE89A9BQ36066083-67328AD0-CB3D-413A-AA83-6D11A1ECB500Q36147921-2E92027D-7939-41AB-9E3E-4C29EFBEA49AQ36150530-C8D5FBCD-7A3F-4A57-B3F1-8AC6BB799C02Q37000733-14A0E77E-E158-429B-96C5-7E9F5EE794FBQ37257317-1CF99EBD-0071-465E-8386-871F04AA266AQ37644125-6B30D04E-BC39-4F0C-8A68-122E93019F3DQ37837963-AF41849C-0224-431C-AD46-DBB030372E2EQ38124737-D1129477-9874-4A87-910F-6C1A29025E70Q38512161-ED270AB6-09DD-4AE4-8DF9-0B6A0B3B812AQ38539281-58938965-F046-421D-8DF8-A9BAF433B397Q42175356-557B4FFE-106B-4507-A95A-43174E01D82EQ42215012-58139966-6CE3-44CC-B151-8D14A1FA9AEAQ42272317-989DD696-BBD9-4307-8419-3725689208E2Q45357722-327253C8-4F1E-4B43-B84A-FB532E58F6CDQ46080960-FC038A80-506E-475E-9388-31691E26458BQ50956303-63C5C53E-73E5-4BAA-BD4C-7CACEB950E4EQ51825330-D62B398F-AE41-435C-8B25-79E3706C42A7
P2860
Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Management of drug-to-drug int ...... planted HIV-infected patients.
@en
Management of drug-to-drug int ...... planted HIV-infected patients.
@nl
type
label
Management of drug-to-drug int ...... planted HIV-infected patients.
@en
Management of drug-to-drug int ...... planted HIV-infected patients.
@nl
prefLabel
Management of drug-to-drug int ...... planted HIV-infected patients.
@en
Management of drug-to-drug int ...... planted HIV-infected patients.
@nl
P2093
P2860
P356
P1476
Management of drug-to-drug int ...... planted HIV-infected patients.
@en
P2093
Andreas Türler
Esther Voigt
Hans-Christoph Michaelis
Jürgen Kurt Rockstroh
Martin Vogel
Martin Wolff
Thomas Sudhop
Tilman Sauerbruch
Ulrich Spengler
P2860
P304
P356
10.1002/LT.20165
P577
2004-07-01T00:00:00Z